LDL cholesterol
Biomarker24 papers9 findings
- Human trial3
- Humans12
Interventions
6Diet
downin humans1
1 study
Diet
downin humans1
Diet decreases LDL cholesterol in humans.
“LDL-cholesterol decreased in both Opti and LCHF Opti groups versus control”
Human trial4 weeks
Optimized Nutri-Dense meals versus a low-carbohydrate high-fat diet: an exploratory randomized controlled trial · Scientific reports · 3 Oct 2026
Tirzepatide
downin humans1
1 study
Tirzepatide
downin humans1
Tirzepatide decreases LDL cholesterol in humans.
Humanstype 2 diabetes4.5 ± 1.0 mg/week24 weeksn = 88
Real-world effectiveness and safety of low-dose tirzepatide in Japanese people with type 2 diabetes: a multicenter, retrospective, single-arm, observational study-East Shizuoka Tirzepatide (ESTATE) study · Endocrine journal · 29 Sep 2026
Statins
downin humans1
1 study
Statins
downin humans1
Statins decrease LDL cholesterol in humans (donut estimates vary from - 1.00 to - 1.72 mmol/L).
Humansaround the first recorded prescription date
Event-time regression discontinuity for biomedical data: LATT estimation and covariate distribution tests · American journal of epidemiology · 29 Sep 2026
Inclisiran
downin humans1
1 study
Inclisiran
downin humans1
Inclisiran decreases LDL cholesterol in humans (-46% (-60.8 to -33.8%)).
Humans3 years43.1% femalesn = 109
Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network · Clinical research in cardiology : official journal of the German Cardiac Society · 28 Sep 2026
Lerodalcibep
downin humans1
1 study
Lerodalcibep
downin humans1
Lerodalcibep decreases LDL cholesterol in humans (50% to 65%).
Reviewin patients with heterozygous familial hypercholesterolemia, established cardiovascular disease, or high cardiovascular riskmonthly
Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia · The Annals of pharmacotherapy · 25 Sep 2026
Mediterranean diet
downin humans1
1 study
Mediterranean diet
downin humans1
Mediterranean diet decreases LDL cholesterol in humans.
Review
Lifestyle Medicine and the Science of Cholesterol Reduction: A Systematic Review of Non-medication Approaches Among Adults · Cureus · 30 Aug 2026
Upstream
2Cysteine-glutathione disulfide
upin humans1
1 study
Cysteine-glutathione disulfide
upin humans1
Cysteine-glutathione disulfide increases LDL cholesterol in humans.
“Genetically predicted 2-amino-octanoate and cysteine-glutathione disulfide demonstrated strong and reproducible positive interaction effects with LDL levels in statin users”
Humansin statin users
Gene-Environment Interaction Mendelian Randomization Reveals Statin-Dependent Associations Between Metabolites and Lipid Traits · Pharmaceuticals (Basel, Switzerland) · 17 Sep 2026
2-amino-octanoate
upin humans1
1 study
2-amino-octanoate
upin humans1
2-amino-octanoate increases LDL cholesterol in humans.
“Genetically predicted 2-amino-octanoate and cysteine-glutathione disulfide demonstrated strong and reproducible positive interaction effects with LDL levels in statin users”
Humansin statin users
Gene-Environment Interaction Mendelian Randomization Reveals Statin-Dependent Associations Between Metabolites and Lipid Traits · Pharmaceuticals (Basel, Switzerland) · 17 Sep 2026
Associations
1APOE
upin humans1
1 study
APOE
upin humans1
APOE is associated with LDL cholesterol in humans.
Reviewε4 isoform
Apolipoprotein E ε3/ε4 and coronary artery disease: lipid and non-lipid mechanisms in personalized prevention - narrative review · Frontiers in cardiovascular medicine · 18 Sep 2026
Latest
29Apolipoprotein E ε3/ε4 and coronary artery disease: lipid and non-lipid mechanisms in personalized prevention - narrative review
Optimized Nutri-Dense meals versus a low-carbohydrate high-fat diet: an exploratory randomized controlled trial
Retinal vascular changes track mortality risk in humans
Increased retinal fractal dimension carried a mortality hazard ratio of 0.92 per standard deviation, whereas arteriolar widening carried a hazard…Increased retinal fractal dimension carried a mortality hazard ratio of 0.92 per standard deviation, whereas arteriolar widening carried a hazard ratio of 1.09.
Lipoprotein(a) in the statin era: from risk marker to therapeutic target
Comparative efficacy of exercise modalities on cardiometabolic health in older adults: A systematic review and network meta-analysis
Social context predicts heart risks despite normal biomarkers
Below target cutoffs, participants with less favorable social context had cardiovascular event rates of 3.39 versus 1.68, 7.16 versus 2.05, and 8.67…Below target cutoffs, participants with less favorable social context had cardiovascular event rates of 3.39 versus 1.68, 7.16 versus 2.05, and 8.67 versus 2.34 per 1,000 person-years.